Deltex Medical Group plc
DTXMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $1 | $5 | $13 |
| - Cash | $0 | $1 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $6 | $2 | $6 | $14 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 15.8% | -28.4% | 9.9% | – |
| Gross Profit | $1 | $1 | $2 | $2 |
| % Margin | 68% | 63.3% | 74.1% | 69.7% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -39.3% | -51.7% | -33% | -30.6% |
| Net Income | -$2 | -$1 | -$1 | -$1 |
| % Margin | -87.4% | -72.2% | -46.1% | -42.8% |
| EPS Diluted | -0.001 | -0.001 | -0.002 | -0.002 |
| % Growth | 18.2% | 35.3% | 0% | – |
| Operating Cash Flow | -$0 | -$1 | -$1 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$0 | -$2 | -$1 | -$1 |